Atıf Formatları
Dronedarone as a new treatment option for atrial fibrillation patients: pharmacokinetics, pharmacodynamics and clinical practice.
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

B. Pamukcu And G. Lip, "Dronedarone as a new treatment option for atrial fibrillation patients: pharmacokinetics, pharmacodynamics and clinical practice.," Expert opinion on pharmacotherapy , vol.12, pp.131-40, 2011

Pamukcu, B. And Lip, G. 2011. Dronedarone as a new treatment option for atrial fibrillation patients: pharmacokinetics, pharmacodynamics and clinical practice.. Expert opinion on pharmacotherapy , vol.12 , 131-40.

Pamukcu, B., & Lip, G., (2011). Dronedarone as a new treatment option for atrial fibrillation patients: pharmacokinetics, pharmacodynamics and clinical practice.. Expert opinion on pharmacotherapy , vol.12, 131-40.

Pamukcu, BURAK, And GY Lip. "Dronedarone as a new treatment option for atrial fibrillation patients: pharmacokinetics, pharmacodynamics and clinical practice.," Expert opinion on pharmacotherapy , vol.12, 131-40, 2011

Pamukcu, BURAK And Lip, GY. "Dronedarone as a new treatment option for atrial fibrillation patients: pharmacokinetics, pharmacodynamics and clinical practice.." Expert opinion on pharmacotherapy , vol.12, pp.131-40, 2011

Pamukcu, B. And Lip, G. (2011) . "Dronedarone as a new treatment option for atrial fibrillation patients: pharmacokinetics, pharmacodynamics and clinical practice.." Expert opinion on pharmacotherapy , vol.12, pp.131-40.

@article{article, author={BURAK PAMUKÇU And author={GY Lip}, title={Dronedarone as a new treatment option for atrial fibrillation patients: pharmacokinetics, pharmacodynamics and clinical practice.}, journal={Expert opinion on pharmacotherapy}, year=2011, pages={131-40} }